Pacira BioSciences Sees FY2026 Sales $745.000M-$770.000M vs $790.214M Est.
Benzinga Newsdesk 8 months ago
NewsGuidance
Pacira BioSciences (NASDAQ:PCRX) sees FY2026 sales of $745.000 million-$770.000 million vs $790.214 million analyst estimate.
Pacira BioSciences (NASDAQ:PCRX) sees FY2026 sales of $745.000 million-$770.000 million vs $790.214 million analyst estimate.